| Source HCPCS Code |
|
Target NDC Code |
Q3027
|
⇄
|
59627-0001-03
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q3027
|
⇄
|
59627-0002-05
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q3027
|
⇄
|
59627-0003-04
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q3027
Injection, interferon beta-1a, 1 mcg for intramuscular use
|
⇄
|
59627-0222-05
AVONEX PREFILLED SYR 30 MCG KIT
|
| Detail Information |
| Relationship Start Date |
01/01/2014 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
KIT |
| Route Of Administration |
IM |
| Billing Units |
EA |
|
|
|
Q3027
Injection, interferon beta-1a, 1 mcg for intramuscular use
|
⇄
|
59627-0333-04
AVONEX PEN 30 MCG/0.5 ML KI
|
| Detail Information |
| Relationship Start Date |
04/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
KIT |
| Route Of Administration |
IM |
| Billing Units |
EA |
|
|
|